Glycine

    VTB
    Specifications
    HS Code 417889
    Product Name Glycine
    Synonyms Aminoacetic acid; Gly; G; Aminoethanoic acid
    Cas Number 56-40-6
    Einecs Number 200-272-2
    Iupac Name 2-aminoacetic acid
    Chemical Formula C2H5NO2
    Molecular Weight 75.07 g/mol
    Category Amino acid
    Grade Food grade; Pharmaceutical grade; Industrial grade
    Appearance White crystalline powder
    Odor Odorless
    Taste Sweet
    Melting Point 233 °C (decomposes)
    Density 1.607 g/cm³
    Solubility Soluble in water; slightly soluble in ethanol; insoluble in ether
    Ph 5.5-7.0 (5% aqueous solution)
    Pka 2.34 (carboxyl), 9.60 (amino)
    Logp -3.21
    Assay 99.0%-101.0%
    Loss On Drying ≤0.2%
    Residue On Ignition ≤0.1%
    Heavy Metals ≤10 ppm
    Storage Store in a cool, dry, tightly sealed container
    Shelf Life 2 years
    Packaging 25 kg bag or drum

    As an accredited Glycine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Glycine supplied in securely sealed 25 kg polyethylene-lined fiber drums, labeled with standard product name, lot number, and handling information.
    Container Loading (20′ FCL) Loading Glycine into a 20′ FCL: palletized 25 kg bags, clean dry container, evenly stowed, secured for safe ocean shipment.
    Shipping Glycine is generally not classified as dangerous goods for transport by DOT, IATA, IMDG, or ADR. Ship in clean, dry, sealed containers with appropriate labeling. Keep away from moisture, heat, and strong oxidizers. No special transport precautions are required beyond standard chemical handling and compliance with local regulations.
    Storage Store glycine at room temperature in a cool, dry, well-ventilated area. Keep containers tightly closed when not in use to prevent moisture uptake and contamination. Protect from heat, direct sunlight, and incompatible substances such as strong oxidizers. Use clearly labeled, corrosion-resistant containers and secondary containment where required. Maintain good housekeeping, avoid dust generation, and follow local regulations.
    Shelf Life Glycine is stable; store dry, sealed, at room temperature. Typical shelf life is 2–5 years; properly stored, it may last indefinitely.
    Application of Glycine

    In herbicidal active ingredient synthesis, glycine functions as the primary nitrogen-bearing C2 intermediate in the dimethyl phosphite route to N-(phosphonomethyl)glycine, a non-selective systemic herbicide. The condensation is carried out in a glass-lined jacketed reactor of 5,000 L working volume equipped with an anchor agitator operating at 40–60 rpm and a Coriolis mass-flow-controlled dimethyl phosphite feed. A representative batch charges glycine (1.00 kmol, 75.07 kg) with methanol (2.5–3.5 L per kg glycine), paraformaldehyde equivalent to 1.05–1.10 mol formaldehyde per mol glycine, and triethylamine at 0.03–0.05 mol per mol glycine. Paraformaldehyde is first depolymerised in methanol at 50–55 °C until the solution clears; glycine is then suspended, and dimethyl phosphite (1.05–1.15 mol per mol glycine) is metered over 2–3 h while the jacket holds the batch at 45–55 °C. The exotherm is controlled by limiting the dimethyl phosphite addition rate rather than allowing the batch temperature to exceed 60 °C, above which dimethyl phosphite hydrolysis to phosphorous acid accelerates and reduces yield. After the Mannich condensation, 30% hydrochloric acid is added to pH 1.5–2.0, and hydrolysis is carried out at 85–90 °C for 2–4 h. Methanol is recovered by vacuum distillation at −0.06 to −0.08 MPa, and the glyphosate is crystallised by cooling to 5–10 °C over 4 h, recovered in a bottom-discharge centrifuge, and dried in a vacuum tray dryer at 60–70 °C with residual moisture below 0.5%. Batch records from production-scale lines typically report yields of 86–91% on glycine and technical purity above 95% when analysed by reversed-phase HPLC after FMOC-Cl derivatisation; the main impurities include unreacted glycine, aminomethylphosphonic acid, and N-methylglyphosate. The mother liquor contains formate, chloride, phosphite, and unreacted glycine; published data for the complete mass balance of this specific configuration is limited, but waste-stream treatment generally requires oxidation of phosphite and formaldehyde before biological treatment. The operational boundary is fixed by formaldehyde handling: off-gas from the reactor and dryer must be routed through a caustic scrubber, and residual formaldehyde in the dried technical solid is kept below 0.2% because higher levels complicate downstream formulation.

    Chelation of Trace Metals with Glycine in Foliar Fertilizer Concentrates

    Glycine is used in foliar nutrient production because its zwitterionic carboxylate and α-amino groups coordinate divalent transition-metal cations under mildly acidic conditions, forming complexes that remain soluble in liquid formulations without the high stability constants of EDTA. The reaction is performed in a 5,000 L polypropylene-lined stirred tank with pH-controlled dosing of aqueous ammonia or sulfuric acid, nitrogen sparging at 0.5–1.0 L/min, and heating to 60–70 °C. For zinc, manganese, and copper sulphates, the glycine-to-metal molar ratio is held at 2.0–2.5:1; for ferrous sulphate, the ratio is increased to 2.5–3.0:1 to suppress free ferric iron precipitation. The metal sulphate is dissolved separately in deionised water, glycine is added under agitation, and the pH is adjusted to 5.0–6.5 and held for 90–120 min. Chelation efficiency is measured after passage through a 1 kDa ultrafiltration membrane and elemental analysis by ICP-OES according to ISO 11885; typical production batches show chelated fractions above 92% at pH 5.5 for zinc and manganese, whereas ferrous glycine drops to below 80% at pH 7.0 because oxidative hydrolysis to ferric oxyhydroxide competes with ligand coordination. Finished liquid concentrates containing 6.0% Zn, 4.0% Mn, or 3.5% Fe are filtered through 0.45 µm cartridges before filling into HDPE jerrycans or totes. The formulation is incompatible with phosphate and carbonate carriers: mixing a 6% zinc glycine concentrate with 10% potassium dihydrogen phosphate solution causes precipitation within 24 h, so tank-mix instructions must specify separate dissolution. In calcareous soils with soil solution pH above 7.5, calcium and magnesium compete for the glycine ligand and reduce plant-available metal fraction; this limits the use of glycine chelates to acidic-to-neutral soils or foliar application where the leaf-surface pH remains below 6.5. Published data for field efficacy at high pH is limited, and distributors should not extend the product into alkaline fertigation programs without jar testing.

    High-aspect-ratio PCB through-holes and blind microvias require a copper deposition regime in which cyanide-free alkaline glycine baths maintain cupric ion solubility while lowering deposition rate sufficiently to produce conformal microcrystalline copper. The bath is prepared from 0.10–0.15 M copper sulphate pentahydrate, 0.30–0.45 M glycine, and potassium hydroxide to pH 10.5–11.0; the glycine-to-copper molar ratio of 2.5–3.0:1 stabilises the Cu(Gly)₂ complex, whose cumulative formation constant log β₂ is approximately 15.2 at 25 °C and ionic strength 0.5 M. Operating temperature is maintained at 50–60 °C in a heated polypropylene plating tank with continuous filtration through 5 µm polypropylene cartridges and air agitation at 0.2–0.5 L/min·L of bath volume. Strike plating is conducted at 1–3 A/dm² for 2–5 min to cover the electroless copper seed layer, followed by full-thickness deposition at 4–6 A/dm² for through-hole and blind-via filling. Cathodic polarisation measured in a three-electrode cell with a rotating disk electrode at 900 rpm shows a mixed kinetic-diffusion plateau between −0.6 V and −0.9 V versus SCE; this suppresses dendrite formation on high-current-density edges. The bath is incompatible with insoluble mixed-metal oxide anodes operated at current densities above 10 A/dm² because glycine undergoes oxidative degradation, generating cyanate and ammonia that shift pH and reduce throwing power; soluble oxygen-free copper anodes with anode bags are preferred. Throwing power is evaluated in a Haring-Blum cell with a 1:5 cathode-to-anode spacing ratio, and production baths are adjusted with glycine and KOH based on titration of free glycine by formal titration and copper by iodometric titration. Deposit thickness is measured microscopically on a cross-section according to ASTM B487, with a target average of 25 µm in the barrel of the through-hole. The operational boundary for glycine concentration is narrow: below 0.25 M, the bath loses conductivity and precipitates copper hydroxide at the cathode boundary layer; above 0.50 M, the bath viscosity increases and leveling performance decreases. Published data for this specific configuration in blind-microvia filling is limited, and manufacturers qualify each bath on production-scale panels because laboratory Hull-cell data do not predict high-aspect-ratio fill behaviour.

    What Limits Glycine-HCl Elution in Protein A Affinity Chromatography?

    Buffer selection for the capture of recombinant monoclonal antibodies by Protein A affinity chromatography is constrained by the need to release bound immunoglobulin without denaturing the eluting protein, and 100 mM glycine-HCl at pH 3.0–3.5 is widely specified because its carboxylate pKₐ of 2.34 places moderate buffering capacity within the target elution window. The buffer is prepared by dissolving glycine in water for injection to 100–150 mM, adjusting to pH 3.2±0.1 with 1 M hydrochloric acid, and filtering through a 0.2 µm sterilising-grade filter; conductivity is typically 3–5 mS/cm at 20–25 °C, and endotoxin is controlled below 0.25 EU/mL for clinical manufacturing. The Protein A column is equilibrated with 25 mM Tris or phosphate-buffered saline at pH 7.0–7.4, loaded at 150–300 cm/h linear velocity, washed, and eluted with the glycine-HCl buffer in a volume of 3–5 column volumes. Eluate collection begins when UV₂₈₀ absorbance exceeds 0.5 AU and ends when it falls below 0.5 AU; the eluate is then neutralised to pH 7.0 with 1 M Tris base before low-pH viral inactivation at pH 3.3–3.6 for 30–60 min at 20±2 °C. Glycine-HCl has low ionic strength and does not chelate metal ions strongly, which minimises corrosion risk to stainless steel chromatography skids; however, its buffering capacity is negligible above pH 4.0, so pH excursions occur if the column has not been fully equilibrated or if the protein load contains residual cell culture medium with bicarbonate. The main operational limitation is pH drift during long elution steps because the low-pH buffer absorbs low amounts of carbon dioxide at pH 3.2; more importantly, glycine solutions should be stored at 2–8 °C to prevent microbial growth, as they support Gram-negative growth at ambient temperature. Published data for column reuse beyond 200 cycles with this buffer is site-specific, but resin manufacturers routinely qualify 100 mM glycine-HCl as a standard elution buffer for alkaline-stable Protein A ligands.

    Monogastric feed formulation relies on digestible amino acid ratios rather than crude protein; glycine is conditionally essential in broiler starter and laying hen rations where corn-soybean meal diets deliver less glycine than the bird synthesizes. In prestarter and starter feeds, technical-grade glycine is added at 0.20–0.40 wt% of the finished feed, typically to maintain the standardised ileal digestible glycine+serine to lysine ratio above 1.30–1.45; the exact inclusion depends on the digestible lysine content, which is usually 1.25–1.35% in prestarter crumble. Raw-material glycine is weighed with an accuracy of ±0.1 kg per tonne and added to the mixer premix; feed mills use a horizontal twin-shaft paddle mixer with a coefficient of variation below 5% after 3–5 min of dry mixing. The glycine particle size is specified as 95% passing 0.25 mm to prevent segregation in vertical screw conveyors and to ensure even distribution in the final mash or crumble. A typical prestarter formulation contains 22.0% crude protein, 1.25% digestible lysine, 0.55% digestible methionine, and 0.85% digestible glycine+serine before adjustment; glycine addition raises the glycine+serine to lysine ratio and reduces the need for soybean meal, thereby lowering potassium and oligosaccharide load. Pellet quality is measured by a Holmen tester with a target durability above 90%; glycine itself does not act as a binder, so formulation changes may require 0.5–1.0% molasses or lignosulfonate to maintain pellet durability. Glycine is not hygroscopic at ambient humidity but should be stored below 60% relative humidity to prevent caking. The addition of glycine above 0.50% in broiler starter may depress feed intake because excessive amino acid imbalances increase plasma uric acid and reduce palatability; published dose-response data for this specific configuration is limited, but production nutritionists avoid oversupplementation because feed-grade glycine cost does not justify marginal improvements beyond 0.45%. Compliance with labelling is determined by ion chromatography with post-column ninhydrin detection on acid-hydrolysed feed samples.

    When Parenteral Lyophilisation Requires a Bulking Agent with Buffering Capacity at pH 2.5–3.5

    The freeze-drying behaviour of parenteral formulations containing acid-labile peptides or low-pH monoclonal antibody drug products is influenced by the crystallisation tendency and pH buffering of glycine as a bulking agent. Glycine is incorporated at 20–50 mg/mL in the pre-lyophilisation solution, frequently together with 5–10 mM histidine or citrate buffer, and the pH is adjusted to 3.0–3.5 with hydrochloric acid before 0.2 µm filtration. During freezing, glycine forms a crystalline matrix that prevents collapse during primary drying; differential scanning calorimetry shows a eutectic event in the range of −6 to −2 °C for the aqueous glycine system, which allows primary drying at a shelf temperature of −15 to −20 °C and chamber pressure of 80–120 mTorr. The lyophilisation cycle is developed in a laboratory freeze dryer with a capacitance manometer and a shelf mapping study of ±1 °C uniformity; primary drying is considered complete when the product thermocouple temperature converges with the shelf set-point and the chamber pressure remains stable for 2 h. Residual moisture in the finished cake is measured by Karl Fischer titration and is typically controlled below 1.0%. Glycine at this pH provides buffering capacity but the glycine-HCl system has low ionic strength; tonicity contributions are often adjusted with mannitol or trehalose if the formulation requires isotonicity. The main limitation is that glycine can crystallise as a hydrate and produce a friable cake that is more sensitive to mechanical shock during vial handling; also, glycine may not protect labile proteins from freeze-induced surface denaturation as effectively as amorphous disaccharides such as sucrose or trehalose. Published data for protein stability in glycine-crystallising systems is product-specific, and lyophilisation formulators typically compare glycine-containing cakes against mannitol and sucrose-placebo formulations using size-exclusion chromatography and subvisible particle counting after thermal stress at 40 °C for 4 weeks. Batch equipment for commercial scale includes stainless steel lyophilizer shelves with a shelf area of 20–40 m² and stoppering under nitrogen; the glycine-containing product is filled under aseptic conditions with a fill volume tolerance of ±0.1 mL.

    Free Quote

    Competitive Glycine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615380400285 or mail to sales2@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615380400285

    Email: sales2@ascent-chem.com

    Inquiry

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Glycine (CAS 56-40-6, NH₂CH₂COOH, molar mass 75.07 g mol⁻¹) is the simplest proteinogenic amino acid and is manufactured as a white crystalline powder or free-flowing crystals with a characteristic sweet taste. The α-carbon carries two hydrogen substituents, so the molecule is achiral and no optical rotation specification appears in the pharmacopeial monographs; this is a primary difference from L-alanine, L-serine, and L-proline, which require enantiomeric identity and optical rotation controls. Aqueous solubility is approximately 25 g/100 mL at 25 °C, while solubility in ethanol and ether is negligible. The ionizable groups produce pKₐ values of 2.34 and 9.60, with an isoelectric point of 5.97. Commercial production is dominated by the Strecker synthesis from formaldehyde, sodium cyanide, and ammonium chloride, or by ammonolysis of monochloroacetic acid; in both routes, residual chloride, ammonia, cyanide-derived impurities, and heavy metals constitute the principal release risks. The product is offered in pharmacopeial, food additive, feed, and technical models, with grade boundaries set by assay, loss on drying, residue on ignition, chloride, sulfate, and endotoxin documentation.

    What Limits the Use of Technical-Grade Glycine in Injectable and Food Applications?

    Technical-grade glycine is not interchangeable with pharmacopeial grade in parenteral, ophthalmic, or oral dosage forms. The critical differences are not only assay but impurity burden and documentation control. The USP-NF monograph requires assay 98.5–101.5% on the dried basis, loss on drying ≤0.20% after drying at 105 °C for 2 h according to USP <731>, residue on ignition ≤0.10% according to USP <281>, chloride ≤0.007%, sulfate ≤0.006%, iron ≤10 mg kg⁻¹, and pH 5.5–6.5 for a 5% aqueous solution. The European Pharmacopoeia Glycine monograph applies a similar profile; the JP monograph supports drug-substance and excipient use in Japan. FCC-grade material supports food additive use but does not carry the same bacterial endotoxin or particulate documentation as parenteral-excipient batches. Technical material used in metal finishing or glyphosate synthesis may show chloride at 0.1–0.4% and sulfate at 0.1–0.3% in vendor certificates of analysis, values that are unacceptable for injectable formulary use. The table below summarizes representative grade-release data.

    Representative release data for glycine grades
    ParameterPharmacopeial gradeFood additive gradeTechnical grade
    Assay98.5–101.5% (dried basis)98.5–101.5% (dried basis)≥98.0% (as-is)
    Loss on drying≤0.20%≤0.20%≤0.50%
    Residue on ignition≤0.10%≤0.10%≤0.50%
    Chloride (as Cl)≤0.007%Vendor-defined≤0.40%
    pH (5% solution)5.5–6.55.5–6.55.0–6.5

    In food and beverage applications, glycine is assigned E 640 under the EU additive nomenclature and is listed in 21 CFR 582.5049 as a generally recognized as safe substance for specific food uses in the United States. Its relative sweetness is approximately 0.6–0.7 compared with sucrose, which permits partial sugar replacement in certain acidified beverages without adding a persistent aftertaste. The buffering effect is derived from the zwitterionic equilibrium between the ammonium and carboxylate groups, not from added counterions, so pH adjustment can be achieved with minimal sodium or potassium contribution. In protein-rich nutritional bars, glycine may compete with lysine and arginine in Maillard browning; published data for long-term storage stability under accelerated conditions is formulation-specific, and the product should not be assumed inert in reducing-sugar matrices. Feed-grade glycine is used in broiler and swine premixes to balance glycine-plus-serine supply for collagen and uric acid synthesis; the choice between crystalline glycine and glycine-rich raw materials is driven by chloride tolerance and dry-mixing homogeneity.

    Buffering, Metal Chelation, and Electroplating Bath Performance Data

    Glycine acts as a zwitterionic buffer in two distinct pH windows that correspond to its pKₐ values. The glycine–HCl system is useful between approximately pH 2.2 and 3.6, and the glycine–NaOH system buffers between approximately pH 8.6 and 10.6. In enzyme stabilization and diagnostic reagents, glycine is used at concentrations from 50 mM to 200 mM; the concentration must be matched to the assay because glycine can chelate essential divalent cations such as Cu²⁺ and Zn²⁺. For electroless and electroplating baths, glycine forms five-membered chelate rings with transition metals. Reported stability constants at 25 °C and ionic strength 0.1 M are log K₁ = 8.2 for Cu²⁺, 5.8 for Ni²⁺, and 5.1 for Zn²⁺; these values are lower than the corresponding EDTA constants, allowing post-use metal recovery by sulfide or hydroxide precipitation with less chelant interference. In cyanide-free alkaline copper baths, glycine has been evaluated as a complexing agent because it maintains soluble copper at high pH while avoiding cyanide waste-treatment obligations. Published data for long-term bath turnover in production-scale plating lines remains bath-specific, and current density, anode area, and air agitation must be characterized for each installation.

    Glycine irrigation solution at 1.5% is used in transurethral resection of the prostate as a non-hemolytic, non-electrolytic, and optically clear medium. The product is sterile, nonpyrogenic, and formulated to meet the pharmacopeial monograph for Glycine Irrigation Solution; release tests include sterility under USP <71>, bacterial endotoxins under USP <85>, and particulate matter under USP <788>. The solution has an osmolarity near 200 mOsmol L⁻¹ and pH in the range 5.0–6.5. The absence of sodium chloride prevents electrical conductivity during monopolar electrocautery, which is a direct performance requirement for the resection procedure. Absorption of large volumes through open venous sinuses can produce dilutional hyponatraemia, hypervolaemia, and transient visual disturbance; serum sodium concentration must be monitored during extended procedures. In freeze-dried injectable formulations, glycine serves as a crystalline bulking agent and lyoprotectant, but residual moisture must be controlled below 1.0% for protein-containing products.

    When Glycine Is Compared with β-Alanine, Sarcosine, and Taurine in Formulation Design

    Glycine differs from β-alanine principally in the position of the amino group and the resulting pKₐ shift. Glycine has pKₐ values of 2.34 and 9.60; β-alanine, a C₃ amino acid with the amino group on the terminal carbon, has an alkaline pKₐ closer to 10.2, producing a buffer plateau that is displaced upward by approximately 0.6 pH units. Sarcosine is N-methylglycine and cannot form the same hydrogen-bonding network as glycine; it is also not a substrate for glycine cleavage-system metabolism. Taurine contains a sulfonic acid group instead of a carboxylic acid and is not incorporated into protein. In metal chelation, glycine is smaller than iminodiacetic acid and NTA, and its moderate log K₁ values make it appropriate for micronutrient seed treatments where the metal must be available to the plant after soil reduction. The following table summarizes relevant comparative values for product selection.

    Comparative property data for glycine and related technical additives
    PropertyGlycineβ-AlanineSarcosineTaurine
    Molar mass75.07 g mol⁻¹89.09 g mol⁻¹89.09 g mol⁻¹125.15 g mol⁻¹
    pKₐ₁2.343.552.231.50
    pKₐ₂9.6010.2410.228.74
    Isoelectric point5.976.906.225.12
    ProteinogenicYesNoNoNo

    Industrial consumption of glycine in the manufacture of glyphosate via the glycine–dimethyl phosphite route is a high-volume application that drives technical-grade demand. The process requires a glycine feed with controlled chloride because residual chloride can form corrosive acid gases in the phosphite reactor and accelerate pitting in stainless-steel condensers. Technical material with ≥98.0% assay and low ammonium content is generally preferred. Vendor process data for specific plant configurations are limited; ammonia above several hundred milligrams per kilogram has been reported to alter formaldehyde condensation stoichiometry in some campaigns. Glycine is also used as a complexing agent in metal cleaning and as an intermediate for hydantoin and sarcosine derivatives. In each of these downstream chemistries, the primary amine nitrogen is the reactive center, and batch-to-batch variation in residual ammonium chloride affects both yield and side-product profile.

    Thermal Stability and Incompatibility Boundaries That Limit Downstream Processing

    Glycine is stable in closed containers at 15–25 °C, but thermal processing must respect its melting/decomposition transition. The material melts with decomposition in the range 233–236 °C; at sustained temperatures above approximately 150 °C, discoloration and the evolution of ammonia and carbon dioxide may begin before the melting point. Hot-melt extrusion and melt granulation of glycine-containing formulations therefore require a processing window that is below the threshold of measurable degradation and above the glass transition or melting point of the polymer carrier; when the carrier requires barrel temperatures above 120 °C, a twin-screw extruder with a short residence time and atmospheric venting is used. The primary amine group is reactive toward reducing sugars under Maillard conditions above approximately 60 °C at neutral to alkaline pH, which imposes a practical limit on heat-treated nutritional bars, lactose-containing oral dispersible tablets, and pelleted feed. Glycine should not be blended with strong oxidizing agents or nitrosating agents because the primary amino group can participate in nitrosamine-relevant impurity formation under acidic conditions. Current nitrosamine risk assessments under ICH M7 require formulators to control nitrite and secondary-amine sources when glycine is present in drug products.

    Quality-control testing for pharmacopeial glycine includes identification by infrared absorption and a positive ninhydrin reaction, with assay by non-aqueous titration or validated HPLC. Elemental impurity control follows USP <232> and USP <233>, while residual solvents are controlled under USP <467>. For food grade, the FCC monograph includes identification, assay, loss on drying, residue on ignition, and chloride/sulfate limit tests. The material should be packaged in tight, light-resistant containers and stored below 25 °C at relative humidity below 60% to reduce caking in fine-milled powder. On production-scale filling lines, the powder’s flowability changes with crystal habit; fine-milled glycine may require hopper agitation or low-rate rotary valve feeding to prevent bridging in feed plants and pharmaceutical granulation suites.

    In monogastric feed formulation, glycine is treated as a conditionally essential amino acid because endogenous synthesis may not meet demand during rapid growth. Feed-grade product with a typical assay of 98.5% or 99.0% is blended into premixes, but premix segregation can occur if the particle size distribution differs widely from the carrier. The practical addition level is determined by total glycine-plus-serine requirement relative to dietary crude protein, and the chloride contribution from technical glycine routes is sufficiently low that it does not complicate electrolyte balance in typical poultry or swine diets. When replacing soybean meal or fish meal with lower-protein ingredients, batch mixing uniformity should be verified using feed-sampling protocols because the density of glycine crystals can differ from ground grain carriers.

    Commercial glycine is supplied in 25 kg multi-wall paper bags, 500 kg or 1000 kg super sacks, and pharmaceutical-grade material in fiber drums with double polyethylene liners. Model designations are vendor-specific, but the functional split is pharmacopeial, food, feed, and technical. A pharmacopeial model may carry both USP-NF and EP compliance, while a food model may comply with FCC and E 640 purity criteria. Technical models generally lack endotoxin and residual-solvent documentation and are not supported by regulatory change-control dossiers for pharmaceutical use.